The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Accuracy of the triglyceride to high-density lipoprotein cholesterol ratio for prediction of the low-density lipoprotein phenotype B
Abstract
This study examined the accuracy of a triglyceride/high-density lipoprotein (HDL) cholesterol ratio of 3.8 for the prediction of low-density lipoprotein (LDL) phenotype B. The ratio of 3.8 was based on Adult Treatment Panel recommendations for normal fasting triglycerides (<150 mg/dl) and HDL cholesterol (>40 mg/dl). Fasting blood samples were obtained from 658 patients. LDL phenotype analysis was performed by nuclear magnetic resonance spectroscopy. A triglyceride/HDL cholesterol ratio of 3.8 divided the distribution of LDL phenotypes with 79% (95% confidence interval [CI] 74 to 83) of phenotype B greater than and 81% (95% CI 77 to 85) of phenotype A less than the ratio of 3.8. The ratio was reliable for identifying LDL phenotype B in men and women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and to small, dense LDL particles and higher LDL particle numbers.”
From Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association (2011) · cites this paper as [235]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411
Triglyceride Concentration and Ischemic Heart Disease
Jeppesen, J., Hein, H. O., Suadicani, P., & Gyntelberg, F. (1998) · Circulation · doi:10.1161/01.cir.97.11.1029 · Cited by 678
Fasting Triglycerides, High-Density Lipoprotein, and Risk of Myocardial Infarction
Gaziano, J. M., Hennekens, C. H., O’Donnell, C. J., Breslow, J. L., & Buring, J. E. (1997) · Circulation · doi:10.1161/01.cir.96.8.2520 · Cited by 602
Evidence that triglycerides are an independent coronary heart disease risk factor
Cullen, P. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01127-9 · Cited by 462
Otvos, J. D., Jeyarajah, E. J., Bennett, D. W., & Krauss, R. M. (1992) · Clinical Chemistry · doi:10.1093/clinchem/38.9.1632 · Cited by 420
McNamara, J. R., Campos, H., Ordovás, J. M., Peterson, J., Wilson, P. W. F., & Schaefer, E. J. (1987) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.7.5.483 · Cited by 383
A PROPOSED GENETIC MARKER FOR CORONARY HEART DISEASE RISK
Austin, King, M., VRANIZAN, K. M., & Krauss, R. M. (1990) · Cited by 194
Boizel, R., Benhamou, P., Lardy, B., Laporte, F., Foulon, T., & Halimi, S. (2000) · Diabetes Care · doi:10.2337/diacare.23.11.1679 · Cited by 186
Cited by
Sorted by citations
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
Self-citationHigh Ratio of Triglycerides to HDL-Cholesterol Predicts Extensive Coronary Disease
da Luz, P. L., Favarato, D., Faria‐Neto, J. R., Lemos, P. A., & Chagas, A. C. P. (2008) · Clinics · doi:10.1590/s1807-59322008000400003 · Cited by 385
Diabetes Prevalence and Therapeutic Target Achievement in the United States, 1999 to 2006
Cheung, B. M. Y., Ong, K. L., Cherny, S. S., Sham, P. C., Tso, A. W. K., & Lam, K. S. L. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.047 · Cited by 349
Caloric Sweetener Consumption and Dyslipidemia Among US Adults
Welsh, J. A. (2010) · JAMA · doi:10.1001/jama.2010.449 · Cited by 277
Vega, G. L., Barlow, C. E., Grundy, S. M., Leonard, D. S., & DeFina, L. F. (2014) · Journal of Investigative Medicine · doi:10.2310/jim.0000000000000044 · Cited by 237
“Hanak et al.(16) found a high correlation between the ratio and low-density lipoprotein phenotype B (atherogenic dyslipidemia).”
BackgroundBittner, V., Johnson, B. D., Zineh, I., Rogers, W. J., Vido, D. A., Marroquin, O. C., Merz, C. N. B., & Sopko, G. S. (2009) · American Heart Journal · doi:10.1016/j.ahj.2008.11.014 · Cited by 226
Self-citationBaek, S. J., Nam, G. E., Han, K. D., Choi, S. W., Jung, S. W., Bok, A. R., Kim, Y. H., Lee, K. S., Han, B. D., & Kim, D. H. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-013-0011-3 · Cited by 182
Vanrenterghem, Y., Bresnahan, B., Campistol, J., Durrbach, A., Grinyó, J., Neumayer, H.-H., Lang, P., Larsen, C. P., Mancilla-Urrea, E., Pestana, J. M., et al. (2011) · Transplantation · doi:10.1097/tp.0b013e31820c10eb · Cited by 183
Quispe, R., Manalac, R. J., Faridi, K. F., Blaha, M. J., Toth, P. P., Kulkarni, K. R., Nasir, K., Virani, S. S., Banach, M., Blumenthal, R. S., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.06.057 · Cited by 172
Bala, C. G., Fronea, O. F. G., Pop, D., Pop, C., Caloian, B., Comşa, H., Bozan, C., Matei, C., & Dorobanţu, M. (2019) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2018.0122 · Cited by 147
Sultani, R., Tong, D. C., Peverelle, M., Lee, Y. S., Baradi, A., & Wilson, A. (2019) · Heart Lung and Circulation · doi:10.1016/j.hlc.2019.03.019 · Cited by 119
Vesa, C. M., Popa, L., Popa, A. R., Rus, M., Zaha, A. A., BUNGAU, S. G., Ţiţ, D. M., Aron, R. A. C., & Zaha, D. C. (2020) · Diagnostics · doi:10.3390/diagnostics10050314 · Cited by 101
“Primary prevention of cardiovascular disease with aspirin in diabetics remains controversial and is currently indicated only in secondary prevention [61].”
BackgroundWan, K., Zhao, J., Huang, H., Zhang, Q., Chen, X., Zeng, Z., Zhang, L., & Chen, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123521 · Cited by 90
“Interestingly, the high triglycerides (TG) and low high-density lipoprotein cholesterol (HDL-C) ratio has been correlated strongly with the LDL particle size [6, 7].”
BackgroundSmall, dense low‐density‐lipoproteins and the metabolic syndrome
Rizzo, M., & Berneis, K. K. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.694 · Cited by 94
“the use of the triglyceride/HDL-cholesterol ratio for the prediction of LDL pattern B [62,63].”
MethodCordero, A., Andrés, E., Ordoñez, B., León, M., Laclaustra, M., Grima, A., Luengo, E., Moreno, J., Bes, M., Pascual, I., et al. (2009) · American Journal of Cardiology · doi:10.1016/j.amjcard.2009.07.008 · Cited by 97
Cordero, A., Laclaustra, M., LEON, M., Grima, A., Casasnovas, J. A., Luengo, E., Delrio, A., FERREIRA, I., & Alegría, E. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.08.018 · Cited by 89
“The size of LDL particles is inversely correlated with triglyceride-to-HDL ratio.(31) Subjects with PHT showed intermediate values of both ratios between NT and HT, which demonstrates that prehypertension is an insulin-resistance state and highlights PHT as factor to be dealt with on a preventive basis.”
BackgroundChen, Y., Chang, Z., Liu, Y., Zhao, Y., Fu, J., Zhang, Y., Liu, Y., & Fan, Z. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.11.005 · Cited by 86
Mahdavi‐Roshan, M., Mozafarihashjin, M., Shoaibinobarian, N., Ghorbani, Z., Salari, A., Savarrakhsh, A., & Hekmatdoost, A. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01732-9 · Cited by 77
Turak, O., Afşar, B., Özcan, F., Öksüz, F., Mendi, M. A., Yayla, Ç., Covic, A. C., Bertelsen, N. S., & Kanbay, M. (2015) · Journal of Clinical Hypertension · doi:10.1111/jch.12758 · Cited by 72
Bhalodkar, N. C., Blum, S., & Enas, E. A. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.10.036 · Cited by 69
Willey, J. Z., Rodríguez, C. J., Carlino, R., Moon, Y. P., Paik, M. C., Boden-Albala, B. M., Sacco, R. L., Tullio, M. R. D., Homma, S., & Elkind, M. S. V. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.01.018 · Cited by 68
Chang, T. I., Streja, E., Soohoo, M., Kim, T., Rhee, C. M., Kovesdy, C. P., Kashyap, M. L., Vaziri, N. D., Kalantar‐Zadeh, K., & Moradi, H. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08730816 · Cited by 67
Cheung, B. M. Y., Wat, N. M. S., Man, Y. B., Tam, S., Cheng, C., Leung, G. M., Woo, J., Janus, E. D., Lau, C. P., Lam, T., et al. (2007) · American Journal of Hypertension · doi:10.1038/ajh.2007.19 · Cited by 64
“Am J Public Health 2005; 95(9):1631–1636.”
Konieczna, J., Abete, I., Galmés, A. M., Babió, N., Colom, A., Zulet, M. Á., Estruch, R., Vidal, J., Toledo, E., Díaz‐López, A., et al. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.07.005 · Cited by 62
Nair, D., Carrigan, T., Curtin, R. J., Popović, Z., Kuzmiak, S. A., Schoenhagen, P., Flamm, S. D., & Desai, M. Y. (2009) · Preventive Cardiology · doi:10.1111/j.1751-7141.2008.00011.x · Cited by 60
Kim, Y.-H., Jung, S., Nam, G.-E., Han, K. D., Bok, A. R., Baek, S., Cho, K.-H., Choi, Y. S., Kim, S.-M., Ju, S.-Y., et al. (2014) · Eye · doi:10.1038/eye.2014.43 · Cited by 60
Blood cadmium concentration and lipid profile in Korean adults
Kim, K. (2011) · Environmental Research · doi:10.1016/j.envres.2011.12.008 · Cited by 59
Corey, K. E., Vuppalanchi, R., Wilson, L., Cummings, O. W., Chalasani, N., & CRN, T. N. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13035 · Cited by 57
Qin, H., Chen, Z., Zhang, Y., Wang, L., Ouyang, P., Cheng, L., & Zhang, Y. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13087 · Cited by 54
Tg/Hdl-C Ratio as Cardio-Metabolic Biomarker even in Normal Weight Women
Borrayo, G. (2018) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2018.261 · Cited by 54
Suchitra, M. M., Varikasuvu, S. R., Deepthi, K., Sachan, A., & Narasimha, S. R. P. V. L. (2013) · Europe PMC (PubMed Central) · Cited by 53
Nam, G. E., Cho, K.-H., Park, Y. G., Han, K., Choi, Y. S., Kim, S. M., Lee, K. S., Ko, B. J., Kim, Y., Han, B. D., et al. (2013) · Preventive Medicine · doi:10.1016/j.ypmed.2013.06.008 · Cited by 52
Harris, M. M., Hutchins, A. M., & Fryda, L. (2017) · Journal of Medicinal Food · doi:10.1089/jmf.2016.0114 · Cited by 64
Association of alcohol consumption with lipid profile in hypertensive men
Park, H., & Kim, K. (2012) · Alcohol and Alcoholism · doi:10.1093/alcalc/ags019 · Cited by 50
Triglyceride-to-HDL cholesterol ratio
Yunke, Z., Lü, G., & Zhenyue, C. (2013) · Herz · doi:10.1007/s00059-013-3788-0 · Cited by 45
Remnant cholesterol in patients admitted for acute coronary syndromes
Cordero, A., Álvarez, B. Á., Escribano, D., García‐Acuña, J. M., Cid-Álvarez, B. A., Rodríguez‐Mañero, M., Quintanilla, M. A., Agra-Bermejo, R., Zuazola, P., & González‐Juanatey, J. R. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwac286 · Cited by 44
Miralles, C. S. W., Wollinger, L. M., Marin, D., Genro, J. P., Contini, V., & Bosco, S. M. D. (2015) · PubMed · doi:10.3305/nh.2015.31.5.7773 · Cited by 42
Stan, S., Levy, E. H., DELVIN, E. E., Hanley, J. A., Lamarche, B., O’Loughlin, J. L., Paradis, G., & Lambert, M. A. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.046771 · Cited by 40
“Various cut points for the TG/HDL-C molar ratio suggested to identify adults with the small, dense LDL phenotype (19, 21, 22) include 0.”
Kauffman, R. P., Baker, T. E., Baker, V. M., Kauffman, M. M., & Castracane, V. D. (2009) · Gynecological Endocrinology · doi:10.3109/09513590903184084 · Cited by 40
“8 predicts the presence of LDL phenotype and correlates with insulin resistance and subsequent development of coronary artery disease [33].”
BackgroundCirillo, F., Catellani, C., Lazzeroni, P., Sartori, C., Tridenti, G., Vezzani, C., Fulghesu, A. M., Madeddu, E., Amarri, S., & Street, M. E. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2020.1725967 · Cited by 39
“The TGL/HDL-C ratio was calculated as a marker of cardio vascular disease risk [49].”
BackgroundMethodKim, Y., Nam, G. E., Cho, K.-H., Choi, Y. S., Kim, S. M., Han, B.-D., Han, K., Lee, K. S., Park, C.-H., & Kim, D. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej13-0224 · Cited by 38
Antidiabetogenic action of Morus rubra L. leaf extract in streptozotocin-induced diabetic rats
Sharma, S. B., Gupta, S., Ac, R., Singh, U. R., Rajpoot, R., & Shukla, S. K. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.62.02.0013 · Cited by 38
“The atherogenic index, TG/HDL, has been used to predict CHD and is a marker of small, dense LDL, which is an atherogenic lipoprotein.([56,57]) As the extract produced a favourable effect on these factors, this suggests that it may help to prevent the progression of cardiovascular diseases.”
MethodUsefulness of the LDL-C/apoB ratio in the overall evaluation of atherogenicity of lipid profile
Kaneva, A. M., Потолицына, Н. Н., & Bojko, E. R. (2016) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2016.1195411 · Cited by 38
“High accuracy of AIP for predicting LDL particle size has been shown by many researchers (Bhalodkar et al., 2006; Hanak et al., 2004; Maruyama et al., 2003).”
BackgroundGender differences in obesity related cardiovascular risk factors in Spain
Cordero, A., León, M., Andres, E. M., Ordoñez, B., Laclaustra, M., Grima, A., Pascual, I., Luengo, E., Civeira, F., Pocovı́, M., et al. (2008) · Preventive Medicine · doi:10.1016/j.ypmed.2008.10.024 · Cited by 35
“Changes in lifestyle and dietary patterns have led to an increase in the prevalence of obesity (Hossain et al., 2007, Kumanyika et al., 2008; Peytremann-Bridevaux et al., 2007) and other cardiovascular risk factors, such as hypertension (Panagiotakos et al., 2007), diabetes mellitus (Bonora et al.,…”
BackgroundChen, H., Tsai, W., Chiu, Y., Hsu, S., Pai, M., Yang, J., & Peng, Y. (2015) · Medicine · doi:10.1097/md.0000000000000619 · Cited by 34
“The TG/HDL-C ratio may therefore be an optimal marker to predict CV outcomes in dialysis patients, as it has already been utilized in the general population.1,3,7,9 In our results, a TG/ HDL-C ratio >3.8 also predicted the occurrence of composite CV events, which could be partially explained by reports that a TG/HDL-C…”
BackgroundInfluentialGrzegorzewska, A. E., Adamska, P., Iwańczyk-Skalska, E., Ostromecka, K., Niepolski, L., Marcinkowski, W., Mostowska, A., Warchol, W. J., Żaba, C., & Jagodziński, P. P. (2021) · Scientific Reports · doi:10.1038/s41598-021-86231-0 · Cited by 33
Kang, H., Shim, J., Lee, Y., Lee, J. E., Linton, J. A., Kim, J.-K., & Lee, H.-R. (2011) · Kidney & Blood Pressure Research · doi:10.1159/000323895 · Cited by 33
“Elevated TG/HDL-C is associated with increased levels of small, dense LDL-C particles, which are highly atherogenic [ ,”
Maruthappan, V., & Shree, K. S. (2010) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.71923 · Cited by 32
“[26] The atherogenic index (TG/HDL-C ratio) used to predict risk of CHD and marker of small, dense LDL-C (an atherogenic lipoprotein)[27,28] were significantly reduced by the P.”
Yuan, Y., Sun, W. Y., & Kong, X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.912197 · Cited by 32
“The comparison between the predictive role of the HOMA-IR and its six surrogate IR indices, including the TyG, TG/ HDLC, VAI, LAP, TyG-BMI, and TyG-WC, in incident hypertension has never been conducted before.”
MethodInfluentialBagella, P., Squillace, N., Ricci, E. D., Gulminetti, R., Socio, G. V. D., Taramasso, L., Pellicanò, G. F., Menzaghi, B., Celesia, B. M., Dentone, C., et al. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s203813 · Cited by 30
SHAH, A. S., Urbina, E. M., Khoury, P. R., Kimball, T. R., & Dolan, L. M. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.05.002 · Cited by 30
“Recent data suggests that non-HDL cholesterol (6; 7) and/or lipoprotein ratios including LDL/HDL or TG/HDL (8; 9) may be able to better predict cardiovascular disease risk than the traditional lipid profile.”
BackgroundInfluentialBaş, A. L., Demirci, S., Yazıhan, N., Üney, K., & Kaya, E. E. (2012) · International Journal of Endocrinology · doi:10.1155/2012/947187 · Cited by 31
“A high ratio of triglycerides to HDLcholesterol correlates with LDL phenotype B, small HDL particles, and IR [30–32] and found to be a powerful independent indicator of extensive coronary disease [33].”
BackgroundDharmarajan, S. K., & Arumugam, K. M. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-126 · Cited by 30
“As shown in Table 2, the atherogenic index (TG/ HDL-C ratio) used to predict risk of CHD and marker of small, dense LDL-C (an atherogenic lipoprotein) [28,29] were significantly reduced by the flavone from M.”
MethodRizzo, M., & Berneis, K. K. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x187892 · Cited by 30
Malhotra, J. D., Tonorezos, E. S., Rozenberg, M., Vega, G. L., Sklar, C. A., Chou, J. F., Moskowitz, C. S., Eshelman‐Kent, D. A., Janiszewski, P. M., Ross, R., et al. (2012) · Journal of Lipid Research · doi:10.1194/jlr.p029785 · Cited by 29
Shin, H.-G., Kim, Y.-K., Kim, Y., Jung, Y.-H., & Kang, H. (2017) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2017.38.6.352 · Cited by 28
İşçen, S., & Zhenyue, C. (2013) · Herz · doi:10.1007/s00059-013-3840-0 · Cited by 28
Giorgi, N. D., Michelucci, E., Smit, J. M., Scholte, A. J. H. A., Mahdiui, M. E., Knuuti, J. M., Buechel, R. R., Teresińska, A., Pizzi, M. N., Roque, A., et al. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.11.013 · Cited by 26
Classification of LDL Phenotypes by 4 Methods of Determining Lipoprotein Particle Size
Sninsky, J. J., Rowland, C. M., Baca, A. M., Caulfield, M. P., & Superko, H. R. (2013) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e31829d9d17 · Cited by 26
“We confirmed previous reports that TG, HDL-C, and TG/ HDL-C ratio are correlated with peak LDL size.(33,34) This correlation was stronger when peak LDL size was determined by IM than by sGGE or NMR.”
ResultIs Shift Work Associated with Lipid Disturbances and Increased Insulin Resistance?
Alefishat, E. A., & Farha, R. K. A. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0052 · Cited by 25
Zhou, Y., Yang, G., He, H., Pan, X., Peng, W., & Chai, X. (2020) · BioMed Research International · doi:10.1155/2020/5419846 · Cited by 24
“As a possible alternative, the TG/HDL-c ratio has been considered an easily available atherosclerotic marker [21].”
BackgroundGotti, D., Cesana, B. M., Albini, L., Calabresi, A., Izzo, I., Focà, E., Motta, D., Bellagamba, R., Fezza, R., Narciso, P., et al. (2012) · HIV Clinical Trials · doi:10.1310/hct1305-245 · Cited by 25
Cardiovascular Risk in Xavante Indigenous Population
Soares, L. P., Fabbro, A. D. D., Silva, A., Sartorelli, D. S., Franco, L. F., Kuhn, P. C., Moises, R., Vieira-Filho, J. P., & Franco, L. (2018) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20180090 · Cited by 24
Nam, G. E., Han, K., Kim, D., Park, Y. G., Yoon, Y. J., Kim, Y., Lee, S., Lee, S., & Roh, Y. K. (2014) · Endocrine · doi:10.1007/s12020-014-0411-y · Cited by 22
“8) and high LDL-C to HDL-C ratio (LDLC/HDL-C[2) as lipid abnormalities [4, 17–19].”
BackgroundRegulation of Serum Sphingolipids in Andean Children Born and Living at High Altitude (3775 m)
Barbacini, P., Casas, J., Torretta, E., Capitanio, D., Maccallini, G., Hirschler, V., & Gelfi, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112835 · Cited by 22
Woo, M.-H., Lee, K. O., Chung, D., Choi, J.-W., Kim, S.-H., & Oh, S. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.504219 · Cited by 24
“In addition, THR was shown a better predictor of LDL particle size than LDL-C in nondiabetic patients (18, 37, 42, 43).”
BackgroundTejera, C. H., Minnier, J., Fazio, S., Safford, M. M., Colantonio, L. D., Irvin, M. R., Howard, V. J., Zakai, N. A., & Pamir, N. (2021) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2021.100198 · Cited by 21
Relationship between alcohol consumption and serum lipid levels in elderly Korean men
Park, H., & Kim, K. (2011) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2011.08.014 · Cited by 23
Kim, J., Kang, H., Lee, H.-R., Lee, Y., & Shim, J. (2012) · Journal of Korean Medical Science · doi:10.3346/jkms.2012.27.12.1524 · Cited by 23
“Increased levels of small and dense LDL-C particles, which are highly atherogenic, are associated with elevated TG/HDL-C (25, 26).”
BackgroundAhmed, M. A., Ferede, Y. M., & Takele, W. W. (2022) · PLoS ONE · doi:10.1371/journal.pone.0263138 · Cited by 24
“Low level of High-Density Lipoprotein (HDL): < 40 mg/dl and<50mg/dl for male and female, respectively, otherwise declared to be normal [35].”
BackgroundReducing vascular events risk in patients with dyslipidaemia: an update for clinicians
Hermans, M. P., & Fruchart, J. (2011) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622311413952 · Cited by 20
Okosun, I. S., Okosun, B., Lyn, R., & Airhihenbuwa, C. O. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.11.012 · Cited by 20
Impact of triglycerides on lipid and lipoprotein biology in women
Dayspring, T. D., & Pokrywka, G. S. (2010) · Gender Medicine · doi:10.1016/j.genm.2010.05.002 · Cited by 19
Meneguelli, T. S., Hinkelmann, J. V., de Novaes, J. F., Rosa, C. D. O. B., Filgueiras, M. D. S., Silveira, B. K. S., Shivappa, N., Hébert, J. R., & Hermsdorff, H. H. M. (2019) · Journal of Food and Nutrition Research · doi:10.12691/jfnr-7-7-2 · Cited by 19
“Triglyceride-glucose (TyG) index was calculated according to the formula: Ln [fasting triglycerides (mg/dL) x fasting plasma glucose (mg/dL)/2] and Homeostasis model assessment of insulin resistance (HOMA-IR) by the formula: [(fasting glucose (mg/dL)) x (fasting insulin (μU/mL))] / 405 [36-39].”
MethodKeleş, N. (2016) · Northern Clinics of Istanbul · doi:10.14744/nci.2016.52824 · Cited by 18
“Recently, use of triglyceride (TG)/high-density lipoprotein cholesterol (HDL-C) ratio has been recommended as a simple method to determine insulin resistance and cardiometabolic risk in healthy individuals [7, 8, 9, 10, 11].”
MethodSilveira, B. K. S., de Novaes, J. F., Reis, N. D. A., Lourenço, L. P., Capobiango, A. H. M., Ribeiro, S. A. V., & Hermsdorff, H. H. M. (2018) · Cardiology Research and Practice · doi:10.1155/2018/4585412 · Cited by 18
Triglyceride profile in dyslipidaemia of type 2 diabetes mellitus.
Khan, S. R., Ayub, N., Nawab, S., & Shamsi, T. S. (2008) · PubMed · Cited by 18
Krintus, M., Kuligowska-Prusińska, M., Laskowska, E., Janiszewska, E., & Kubica, J. (2015) · Cited by 17
Cardiovascular risk estimated in individuals with multiple sclerosis: A case-control study
Albuquerque, L. D. S., Damasceno, N. R. T., Maia, F. N., de Carvalho, B. M., Maia, C. S. C., D’Almeida, J. A. C., & de Melo, M. L. P. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103133 · Cited by 19
Saleh, J., Wahab, R. A., Farhan, H., Al-Amri, I. S., & Cianflone, K. (2013) · ISRN Obesity · doi:10.1155/2013/342802 · Cited by 16
Kohli, A., Siddhu, A., Pandey, R. M., & Reddy, K. (2016) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.196020 · Cited by 16
“8, based on recommended levels of normal fasting TG (<150 mg/dL) and normal HDL‐C (≥40 mg/dL), the ratio cutoff used in practice varies slightly with different populations, ethnicities, and medical history.[9,12,18] In addition, keeping in view the measurement errors that are likely to be there and the greater day‐to‐…”
BackgroundMethodGrzegorzewska, A. E., Niepolski, L., Świderska, M. K., Mostowska, A., Stolarek, I., Warchol, W. J., Figlerowicz, M., & Jagodziński, P. P. (2018) · BMC Medical Genetics · doi:10.1186/s12881-018-0708-4 · Cited by 15
Relationship Between Dyslipidemia and Albuminuria in Hypertensive Adults
Lee, S.-H., Kim, D., Kim, Y., Roh, Y. K., Ju, S.-Y., Nam, H.-Y., Nam, G. E., Choi, J.-S., Lee, J.-E., Sang, J.-E., et al. (2016) · Medicine · doi:10.1097/md.0000000000003224 · Cited by 14
Platelet Acetyl-CoA Carboxylase Phosphorylation
Kautbally, S., Lepropre, S., Onselaer, M.-B., Lerigoleur, A., Ginion, A., de Meester, C., Ambroise, J., Boudjeltia, K. Z., Octave, M., Wéra, O., et al. (2019) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2019.04.005 · Cited by 14
“TG/HDL-C ratio, a well-known atherogenic marker, indicates LDL particle size (16), while TGs were shown to correlate with plasma oxLDL levels”
Backgroundda Luz, P. L., Bertini, P. J., & Favarato, D. (2005) · Clinics · doi:10.1590/s1807-59322005000500011 · Cited by 13
Conkbayır, C., Ayça, B., & Ökçün, E. Ö. B. (2015) · PubMed Central · Cited by 13
Moura, R. D. S. D. S. E. S., Vasconcelos, D. F., Freitas, E., de Moura, F. J. D., Rosa, T. T., & Veiga, J. P. R. (2013) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20130210 · Cited by 13
Kim, T., Park, A. Y., Baek, Y., & Cha, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0168137 · Cited by 13
Kim, J. E., Yu, M., Kim, Y. C., Min, S., Ha, J., Lee, J. P., Kim, D. K., Oh, K., Joo, K. W., Ahn, C., et al. (2019) · Clinical and Experimental Nephrology · doi:10.1007/s10157-019-01776-9 · Cited by 12
Davis, S. R., Azene, Z. N., Tonkin, A. M., Woods, R. L., McNeil, J. J., & Islam, R. M. (2024) · Climacteric · doi:10.1080/13697137.2024.2310530 · Cited by 12
“…convenient to them, as opposed to a single laboratory. the measurement of total cholesterol, HDl-c and tg has been internationally standardized [50], and nata accreditation ensures laboratories use assays traceable to internationally recognized standard reference materials. therefore, we do…”
BackgroundSuwannaporn, P., Tester, R. F., Al‐Ghazzewi, F. H., & Artitdit, P. (2015) · Nutrition & Food Science · doi:10.1108/nfs-02-2015-0012 · Cited by 12
Triglyceride–to–HDL Cholesterol Ratio in the Dyslipidemic Classification of Type 2 Diabetes
Wägner, A. M., Pérez, A., Sánchez‐Quesada, J. L., & Ordóñez‐Llanos, J. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1798 · Cited by 12
“Previously described cutoff points were used (1,2,6), as well as that calculated from the regression equation obtained from the samples included in the present study: triglyceride–to–HDL cholesterol ratio 42.”
BackgroundMethodHasegawa, A., Kojima, F., Ueda, M., Tanaka, Y., & Nitta, K. (2016) · Renal Replacement Therapy · doi:10.1186/s41100-016-0069-4 · Cited by 12
“The cut-off value of TG/HDL-C ratio in prediction of CV event in our study was much lower than that in the previous studies [29, 31].”
ResultLipid changes 8 years post gastric bypass in adolescents with severe obesity (FABS-5+ study)
Shah, A. S., Jenkins, T. M., Gao, Z., Daniels, S. R., Urbina, E. M., Kirk, S., Siegel, R., & Inge, T. H. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.141 · Cited by 12
Gupta, S., Sharma, S. B., & Prabhu, K. M. (2009) · PubMed · Cited by 11
Moliterno, P., Donangelo, C. M., Borgarello, L., Pécora, M., Olascoaga, A., Noboa, O. A., & Boggia, J. G. (2021) · Nutrients · doi:10.3390/nu13072213 · Cited by 11
“The TG/HDLc ratio was calculated as an index of cardiovascular risk [24].”
BackgroundMethodInfluentialDécary, S., Dumont, G., Lamarche, B., Hogue, J., Tremblay, A. J., Bergeron, J., & Couture, P. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.11.010 · Cited by 11
Ramistella, V., Wasniewska, M. G., Arasi, S., Catena, M., Velletri, M. R., Corica, D., Santucci, S., & Luca, F. D. (2014) · La Pediatria Medica e Chirurgica · doi:10.4081/pmc.2014.104 · Cited by 10
A 10-year follow-up study of demographic and cardiometabolic factors in HIV-infected South Africans
Phalane, E., Fourie, C. M. T., Mels, C. M. C., & Schutte, A. E. (2019) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2019-034 · Cited by 10
Chen, H., Lee, W., Fang, H., Fang, C.-Y., Chen, C.-J., Yang, C., & Wu, C. (2020) · Medicine · doi:10.1097/md.0000000000022848 · Cited by 10
“A high TG/HDL-C ratio is also correlated with LDL phenotype B,([8]) and small HDL particles,([9]) and is also associated with increased arterial stiffness and impaired heart rate recovery after exercise.”
Background
Metadata
- Authors
- Hanak, V., Munoz, J., Teague, J., Stanley, A., & Bittner, V.
- Affiliations
- Carraway Methodist Medical Center (US)
- University of Alabama at Birmingham (US)
- Corresponding author
- Hanak, Viktor
- ORCID
- Bittner, Vera
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2004-07
- Volume
- 94
- Issue
- 2
- Pages
- 219-222
- ISSN
- 0002-9149 (ISSN-L)
- OpenAlex
- W1981002254
- Cited by
- 167
- References
- 11
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 6 · 2023: 3 · 2022: 10 · 2021: 12 · 2020: 9 · 2019: 12 · 2018: 9 · 2017: 7 · 2016: 6 · 2015: 17 · 2014: 9 · 2013: 13 · 2012: 13
- FWCI
- 3.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- triglyceride to HDL cholesterol ratio, LDL particle size, NMR spectroscopy, dyslipidemia, fasting triglycerides, HDL cholesterol, diagnostic accuracy
- MeSH terms
- Aged, Female, Humans, Cholesterol, HDL, Cholesterol, LDL, Male, Middle Aged, Magnetic Resonance Spectroscopy, Particle Size, Phenotype, Sensitivity and Specificity, Triglycerides, Logistic Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review